Establishment and application of a grading diagnostic model for early detection of severe fever with thrombocytopenia syndrome

建立和应用分级诊断模型,用于早期发现伴血小板减少症的严重发热综合征

阅读:1

Abstract

OBJECTIVE: There is an urgent need to develop a reliable and efficient method for the early identification and diagnosis of severe fever with thrombocytopenia syndrome (SFTS). METHODS: This retrospective multicentre study analysed data from 363 patients with SFTS, which included general information and laboratory datas (white blood cell (WBC) count, platelet (PLT) count, aspartate aminotransferase (AST), creatine kinase (CK), creatine kinase-MB (CKMB), lactate dehydrogenase (LDH), hydroxybutyrate dehydrogenase (HBDH), amylase (AMY) and lipase (LIP), etc.). The indicators with higher positive rates were further combined and graded to establish the diagnostic method. The differential diagnosis was conducted with the same zoonotic diseases of fever and thrombocytopenia in the studied region. Finally, multicentre data were used to verify the method. RESULTS: The indicators with high positive rates were WBC, PLT, CK, CKMB, LDH and LIP. Analysis of combined indicators based on fever revealed that the combined positive rate of WBC and PLT was 79.34%, while that of WBC, PLT, AST, LDH, CK and LIP was 69.81%. This study analysed the combined positive rate of AST, LDH, CK and LIP, which was 75.47%. The reliability of this method was validated using multicentre data. For HFRS, the combined positive rate of WBC and PLT was 36.70% , and that of WBC, PLT, AST, LDH, CK and LIP was 27.33% . Additionally, the combined positive rate of AST, LDH, CK, LIP and serum creatinine (SCR) in HFRS was 48.50% (12.63% in SFTS). For scrub typhus, the combined positive rate of WBC and PLT was 12.00% , and that of WBC, PLT, AST, LDH, CK and LIP was 4.55% . CONCLUSIONS: The present study integrated fever presentation, WBC count, PLT levels and biochemical markers to establish a method for early detection and grading diagnosis of SFTS. This study devised a direct and practical approach to diagnose and better understand the role of pathogens in the disease progression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。